ÂÜÀòÂÒÂ×

Margaret Chu-Moyer is an accomplished professional in the field of medicinal chemistry and drug discovery, currently serving as Vice President of Research at Amgen since April 2009. In this role, Margaret has held various leadership positions focused on small molecule therapeutic discovery, including VP Research and Executive Director for multiple research divisions. Prior to Amgen, Margaret spent nearly 16 years at Pfizer as a Senior Director, where extensive experience was gained in medicinal chemistry and drug discovery for metabolic diseases. Margaret's career began at Abbott Laboratories as a Laboratory Technician specializing in synthetic organic chemistry. Academic qualifications include a PhD in Organic Chemistry from Yale University and a BS in Chemistry from the University of California, Berkeley.